International Conference on Hematology, Blood Disorders and Hematologic Research
“Advancing Hematologic Research and Innovative Therapies for Blood Disorders”
Overview
The International Conference on Hematology, Blood Disorders and Hematologic Research convenes researchers, clinicians, academicians, industry experts, and students for a hybrid program spanning onsite and virtual participation. Centred on the theme “Advancing Hematologic Research and Innovative Therapies for Blood Disorders,” it offers a rigorous platform to exchange knowledge, present cutting-edge research, and foster the interdisciplinary collaborations that move the field forward.
This conference aims to provide a comprehensive scientific platform for discussing the latest advancements, emerging technologies, innovative therapies, and translational research in hematology and blood-related disorders.The conference will bring together leading experts and professionals to exchange scientific knowledge, present groundbreaking discoveries, and foster interdisciplinary collaborations focused on improving diagnosis, treatment, and patient care in hematology.
- Registration deadline
- 10 Mar 2028
- Abstract deadline
- 10 Mar 2028
- Mode
- Hybrid
Conference highlights
A focused scientific program built for knowledge exchange, collaboration, and global research visibility.
Sessions & conference tracks
Thematic tracks spanning clinical practice, translational research, and emerging technologies.
Important dates
- Early Bird registration ends30 Nov 2026
- Abstract submission deadline10 Mar 2028
- Registration deadline10 Mar 2028
- Conference dates10–11 Apr 2028
Confirmed speakers
Speakers for ICHB will be announced as they are confirmed by the organising committee.
Conference committees
The committees for ICHB will be announced soon.
Scientific Program
The detailed program for ICHB will be published once sessions are scheduled.
Submit Abstract
Submit original research, reviews or case reports for oral or poster presentation. Please read the Author Guidelines before submitting.
You'll be asked to sign in or create a free account first.
Register here – ICHB
Choose the category that fits you. Your place is reserved as soon as you register and confirmed once payment is received. Registration closes on 10 Mar 2028.
Early Bird pricing ends 30 Nov 2026.
- Virtual delegates join all live sessions online
- Presenting authors must hold a confirmed registration
- Invoices and certificates are available in your attendee portal
- Early Bird$699
- Regular$899
- Student$299
- Virtual$199
- On-site$899
Sign in or create a free account to register.
Venue & travel
Le Meridien Dubai Hotel & Conference Centre, Dubai, UAE
Joining online? See Hybrid Participation.
Who should attend
Designed for clinicians, researchers, academia, industry, and the next generation of scientists.
Benefits of participation
Supporting Innovation in Hematology
Dedicated platforms connect hematology and cell-therapy startups, diagnostics developers, biotech and pharmaceutical partners, and digital-health innovators — fostering collaboration between researchers, clinicians, and investors to advance the diagnosis and treatment of blood disorders.
The Future of Hematology
Hematology is rapidly evolving through advancements in precision medicine, immunotherapy, stem cell transplantation, genomic diagnostics, artificial intelligence, and targeted therapeutics. This conference aims to support these scientific advancements by promoting innovation, collaboration, education, and global knowledge exchange in hematology and blood disorder research.
What you gain
Every delegate joins a global research ecosystem built around networking, publication, recognition, and industry collaboration.
Global Networking
Build long-term collaborations with researchers, clinicians, entrepreneurs, and policymakers from around the world through curated sessions and exhibition networking.
Publication & Visibility
Strengthen your academic profile through conference proceedings, DOI allocation, abstract publication, digital archiving, and indexing support across global dissemination channels.
Awards & Recognition
Compete for awards recognising outstanding oral and poster presentations, young researchers, startups, and distinguished scientific contributions across disciplines.
Industry–Academia Collaboration
Connect universities, healthcare organisations, startups, and technology providers on a shared platform that translates research into real-world solutions.
Frequently asked questions
Who can attend this conference?
The program is open to researchers, clinicians, academicians, healthcare professionals, industry experts, and students worldwide. Both onsite and virtual delegates are welcome under the hybrid format.
Can I attend virtually?
Yes. The conference runs as a hybrid event, so you can present research, attend keynotes, and join networking activities from anywhere through the digital conference platform.
How do I submit an abstract?
Sign in to your author portal and submit your abstract through the submission form. Each accepted abstract is eligible for oral or poster presentation and is considered for publication and DOI allocation.
Will my research be published?
Accepted work is supported through conference proceedings, abstract publication, DOI allocation, and indexing support, helping you gain international visibility for your research.
Are awards available for presenters?
Yes. Awards recognise outstanding oral and poster presentations, young researchers, and innovative startups across the scientific tracks.
Can I receive an invitation or participation letter?
Registered delegates can request official invitation, acceptance, and participation letters to support travel, funding, and institutional approvals.
Present your research at ICHB 2028
Submit an abstract, secure your place, and join researchers and innovators from across the world — onsite or virtually.